Global Depression Drugs Market Growth (Status and Outlook) 2019-2024
Published On: February 2019
 
Report ID:371288
 
 
Pages: 138




Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

The classification of Depression Drugs includes SSRIs, SNRIs and others, and the proportion of SSRIs in 2016 is about 47%, and the proportion of SNRIs in 2016 is about 34%.Depression Drugs is widely used in hospitals, clinics and other places. The most proportion of Depression Drugs is hospitals, and the proportion in 2016 is 679%. The trend of hospitals is increasing.

Market competition is not intense. Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Depression Drugs market will register a 2.9% CAGR in terms of revenue, the global market size will reach US$ 17300 million by 2024, from US$ 15000 million in 2019. In particular, this report presents the global revenue market share of key companies in Depression Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Depression Drugs market by product type, application, key companies and key regions.

This study considers the Depression Drugs value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

SSRIs

SNRIs

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

Hospitals

Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Intellipharmaceutics

Pfizer

Eli Lilly

Astrazeneca

Lundbeck

Allergan

GSK

Otsuka Pharmaceutical

Takeda

NHU Group

Shionogi

APOTEX

Kanghong Pharma

HUAHAI

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Depression Drugs market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Depression Drugs market by identifying its various subsegments.

Focuses on the key global Depression Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Depression Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Depression Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Depression Drugs Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Depression Drugs Market Size 2014-2024

2.1.2 Depression Drugs Market Size CAGR by Region

2.2 Depression Drugs Segment by Type

2.2.1 SSRIs

2.2.2 SNRIs

2.2.3 Others

2.3 Depression Drugs Market Size by Type

2.3.1 Global Depression Drugs Market Size Market Share by Type (2014-2019)

2.3.2 Global Depression Drugs Market Size Growth Rate by Type (2014-2019)

2.4 Depression Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Depression Drugs Market Size by Application

2.5.1 Global Depression Drugs Market Size Market Share by Application (2014-2019)

2.5.2 Global Depression Drugs Market Size Growth Rate by Application (2014-2019)

3 Global Depression Drugs by Players

3.1 Global Depression Drugs Market Size Market Share by Players

3.1.1 Global Depression Drugs Market Size by Players (2017-2019)

3.1.2 Global Depression Drugs Market Size Market Share by Players (2017-2019)

3.2 Global Depression Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Depression Drugs by Regions

4.1 Depression Drugs Market Size by Regions

4.2 Americas Depression Drugs Market Size Growth

4.3 APAC Depression Drugs Market Size Growth

4.4 Europe Depression Drugs Market Size Growth

4.5 Middle East & Africa Depression Drugs Market Size Growth

5 Americas

5.1 Americas Depression Drugs Market Size by Countries

5.2 Americas Depression Drugs Market Size by Type

5.3 Americas Depression Drugs Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Depression Drugs Market Size by Countries

6.2 APAC Depression Drugs Market Size by Type

6.3 APAC Depression Drugs Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Depression Drugs by Countries

7.2 Europe Depression Drugs Market Size by Type

7.3 Europe Depression Drugs Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Depression Drugs by Countries

8.2 Middle East & Africa Depression Drugs Market Size by Type

8.3 Middle East & Africa Depression Drugs Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Depression Drugs Market Forecast

10.1 Global Depression Drugs Market Size Forecast (2019-2024)

10.2 Global Depression Drugs Forecast by Regions

10.2.1 Global Depression Drugs Forecast by Regions (2019-2024)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Depression Drugs Forecast by Type

10.8 Global Depression Drugs Forecast by Application

11 Key Players Analysis

11.1 Intellipharmaceutics

11.1.1 Company Details

11.1.2 Depression Drugs Product Offered

11.1.3 Intellipharmaceutics Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.1.4 Main Business Overview

11.1.5 Intellipharmaceutics News

11.2 Pfizer

11.2.1 Company Details

11.2.2 Depression Drugs Product Offered

11.2.3 Pfizer Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.2.4 Main Business Overview

11.2.5 Pfizer News

11.3 Eli Lilly

11.3.1 Company Details

11.3.2 Depression Drugs Product Offered

11.3.3 Eli Lilly Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.3.4 Main Business Overview

11.3.5 Eli Lilly News

11.4 Astrazeneca

11.4.1 Company Details

11.4.2 Depression Drugs Product Offered

11.4.3 Astrazeneca Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.4.4 Main Business Overview

11.4.5 Astrazeneca News

11.5 Lundbeck

11.5.1 Company Details

11.5.2 Depression Drugs Product Offered

11.5.3 Lundbeck Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.5.4 Main Business Overview

11.5.5 Lundbeck News

11.6 Allergan

11.6.1 Company Details

11.6.2 Depression Drugs Product Offered

11.6.3 Allergan Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.6.4 Main Business Overview

11.6.5 Allergan News

11.7 GSK

11.7.1 Company Details

11.7.2 Depression Drugs Product Offered

11.7.3 GSK Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.7.4 Main Business Overview

11.7.5 GSK News

11.8 Otsuka Pharmaceutical

11.8.1 Company Details

11.8.2 Depression Drugs Product Offered

11.8.3 Otsuka Pharmaceutical Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.8.4 Main Business Overview

11.8.5 Otsuka Pharmaceutical News

11.9 Takeda

11.9.1 Company Details

11.9.2 Depression Drugs Product Offered

11.9.3 Takeda Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.9.4 Main Business Overview

11.9.5 Takeda News

11.10 NHU Group

11.10.1 Company Details

11.10.2 Depression Drugs Product Offered

11.10.3 NHU Group Depression Drugs Revenue, Gross Margin and Market Share (2017-2019)

11.10.4 Main Business Overview

11.10.5 NHU Group News

11.11 Shionogi

11.12 APOTEX

11.13 Kanghong Pharma

11.14 HUAHAI

12 Research Findings and Conclusion


List of Tables and Figures

Table Product Specifications of Depression Drugs

Figure Depression Drugs Report Years Considered

Figure Market Research Methodology

Figure Global Depression Drugs Market Size Growth Rate 2014-2024 ($ Millions)

Table Depression Drugs Market Size CAGR by Region 2014-2024 ($ Millions)

Table Major Players of SSRIs

Table Major Players of SNRIs

Table Major Players of Others

Table Market Size by Type (2014-2019) ($ Millions)

Table Global Depression Drugs Market Size Market Share by Type (2014-2019)

Figure Global Depression Drugs Market Size Market Share by Type (2014-2019)

Figure Global SSRIs Market Size Growth Rate

Figure Global SNRIs Market Size Growth Rate

Figure Global Others Market Size Growth Rate

Figure Depression Drugs Consumed in Hospitals

Figure Global Depression Drugs Market: Hospitals (2014-2019) ($ Millions)

Figure Global Hospitals YoY Growth ($ Millions)

Figure Depression Drugs Consumed in Clinics

Figure Global Depression Drugs Market: Clinics (2014-2019) ($ Millions)

Figure Global Clinics YoY Growth ($ Millions)

Figure Depression Drugs Consumed in Others

Figure Global Depression Drugs Market: Others (2014-2019) ($ Millions)

Figure Global Others YoY Growth ($ Millions)

Table Global Depression Drugs Market Size by Application (2014-2019) ($ Millions)

Table Global Depression Drugs Market Size Market Share by Application (2014-2019)

Figure Global Depression Drugs Market Size Market Share by Application (2014-2019)

Figure Global Depression Drugs Market Size in Hospitals Growth Rate

Figure Global Depression Drugs Market Size in Clinics Growth Rate

Figure Global Depression Drugs Market Size in Others Growth Rate

Table Global Depression Drugs Revenue by Players (2017-2019) ($ Millions)

Table Global Depression Drugs Revenue Market Share by Players (2017-2019)

Figure Global Depression Drugs Revenue Market Share by Players in 2018

Table Global Depression Drugs Key Players Head office and Products Offered

Table Depression Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table Global Depression Drugs Market Size by Regions 2014-2019 ($ Millions)

Table Global Depression Drugs Market Size Market Share by Regions 2014-2019

Figure Global Depression Drugs Market Size Market Share by Regions 2014-2019

Figure Americas Depression Drugs Market Size 2014-2019 ($ Millions)

Figure APAC Depression Drugs Market Size 2014-2019 ($ Millions)

Figure Europe Depression Drugs Market Size 2014-2019 ($ Millions)

Figure Middle East & Africa Depression Drugs Market Size 2014-2019 ($ Millions)

Table Americas Depression Drugs Market Size by Countries (2014-2019) ($ Millions)

Table Americas Depression Drugs Market Size Market Share by Countries (2014-2019)

Figure Americas Depression Drugs Market Size Market Share by Countries in 2018

Table Americas Depression Drugs Market Size by Type (2014-2019) ($ Millions)

Table Americas Depression Drugs Market Size Market Share by Type (2014-2019)

Figure Americas Depression Drugs Market Size Market Share by Type in 2018

Table Americas Depression Drugs Market Size by Application (2014-2019) ($ Millions)

Table Americas Depression Drugs Market Size Market Share by Application (2014-2019)

Figure Americas Depression Drugs Market Size Market Share by Application in 2018

Figure United States Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Canada Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Mexico Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Table APAC Depression Drugs Market Size by Countries (2014-2019) ($ Millions)

Table APAC Depression Drugs Market Size Market Share by Countries (2014-2019)

Figure APAC Depression Drugs Market Size Market Share by Countries in 2018

Table APAC Depression Drugs Market Size by Type (2014-2019) ($ Millions)

Table APAC Depression Drugs Market Size Market Share by Type (2014-2019)

Figure APAC Depression Drugs Market Size Market Share by Type in 2018

Table APAC Depression Drugs Market Size by Application (2014-2019) ($ Millions)

Table APAC Depression Drugs Market Size Market Share by Application (2014-2019)

Figure APAC Depression Drugs Market Size Market Share by Application in 2018

Figure China Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Japan Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Korea Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Southeast Asia Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure India Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Australia Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Table Europe Depression Drugs Market Size by Countries (2014-2019) ($ Millions)

Table Europe Depression Drugs Market Size Market Share by Countries (2014-2019)

Figure Europe Depression Drugs Market Size Market Share by Countries in 2018

Table Europe Depression Drugs Market Size by Type (2014-2019) ($ Millions)

Table Europe Depression Drugs Market Size Market Share by Type (2014-2019)

Figure Europe Depression Drugs Market Size Market Share by Type in 2018

Table Europe Depression Drugs Market Size by Application (2014-2019) ($ Millions)

Table Europe Depression Drugs Market Size Market Share by Application (2014-2019)

Figure Europe Depression Drugs Market Size Market Share by Application in 2018

Figure Germany Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure France Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure UK Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Italy Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Russia Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Spain Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Table Middle East & Africa Depression Drugs Market Size by Countries (2014-2019) ($ Millions)

Table Middle East & Africa Depression Drugs Market Size Market Share by Countries (2014-2019)

Figure Middle East & Africa Depression Drugs Market Size Market Share by Countries in 2018

Table Middle East & Africa Depression Drugs Market Size by Type (2014-2019) ($ Millions)

Table Middle East & Africa Depression Drugs Market Size Market Share by Type (2014-2019)

Figure Middle East & Africa Depression Drugs Market Size Market Share by Type in 2018

Table Middle East & Africa Depression Drugs Market Size by Application (2014-2019) ($ Millions)

Table Middle East & Africa Depression Drugs Market Size Market Share by Application (2014-2019)

Figure Middle East & Africa Depression Drugs Market Size Market Share by Application in 2018

Figure Egypt Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure South Africa Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Israel Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Turkey Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure GCC Countries Depression Drugs Market Size Growth 2014-2019 ($ Millions)

Figure Global Depression Drugs arket Size Forecast (2019-2024) ($ Millions)

Table Global Depression Drugs Market Size Forecast by Regions (2019-2024) ($ Millions)

Table Global Depression Drugs Market Size Market Share Forecast by Regions

Figure Americas Depression Drugs Market Size 2019-2024 ($ Millions)

Figure APAC Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Europe Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Middle East & Africa Depression Drugs Market Size 2019-2024 ($ Millions)

Figure United States Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Canada Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Mexico Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Brazil Depression Drugs Market Size 2019-2024 ($ Millions)

Figure China Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Japan Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Korea Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Southeast Asia Depression Drugs Market Size 2019-2024 ($ Millions)

Figure India Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Australia Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Germany Depression Drugs Market Size 2019-2024 ($ Millions)

Figure France Depression Drugs Market Size 2019-2024 ($ Millions)

Figure UK Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Italy Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Russia Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Spain Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Egypt Depression Drugs Market Size 2019-2024 ($ Millions)

Figure South Africa Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Israel Depression Drugs Market Size 2019-2024 ($ Millions)

Figure Turkey Depression Drugs Market Size 2019-2024 ($ Millions)

Figure GCC Countries Depression Drugs Market Size 2019-2024 ($ Millions)

Table Global Depression Drugs Market Size Forecast by Type (2019-2024) ($ Millions)

Table Global Depression Drugs Market Size Market Share Forecast by Type (2019-2024)

Table Global Depression Drugs Market Size Forecast by Application (2019-2024) ($ Millions)

Table Global Depression Drugs Market Size Market Share Forecast by Application (2019-2024)

Table Intellipharmaceutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table Intellipharmaceutics Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Intellipharmaceutics Depression Drugs Market Share (2017-2019)

Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors

Table Pfizer Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Pfizer Depression Drugs Market Share (2017-2019)

Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors

Table Eli Lilly Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Eli Lilly Depression Drugs Market Share (2017-2019)

Table Astrazeneca Basic Information, Head Office, Major Market Areas and Its Competitors

Table Astrazeneca Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Astrazeneca Depression Drugs Market Share (2017-2019)

Table Lundbeck Basic Information, Head Office, Major Market Areas and Its Competitors

Table Lundbeck Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Lundbeck Depression Drugs Market Share (2017-2019)

Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors

Table Allergan Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Allergan Depression Drugs Market Share (2017-2019)

Table GSK Basic Information, Head Office, Major Market Areas and Its Competitors

Table GSK Depression Drugs Revenue and Gross Margin (2017-2019)

Figure GSK Depression Drugs Market Share (2017-2019)

Table Otsuka Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors

Table Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Otsuka Pharmaceutical Depression Drugs Market Share (2017-2019)

Table Takeda Basic Information, Head Office, Major Market Areas and Its Competitors

Table Takeda Depression Drugs Revenue and Gross Margin (2017-2019)

Figure Takeda Depression Drugs Market Share (2017-2019)

Table NHU Group Basic Information, Head Office, Major Market Areas and Its Competitors

Table NHU Group Depression Drugs Revenue and Gross Margin (2017-2019)

Figure NHU Group Depression Drugs Market Share (2017-2019)

Table Shionogi Basic Information, Head Office, Major Market Areas and Its Competitors

Table APOTEX Basic Information, Head Office, Major Market Areas and Its Competitors

Table Kanghong Pharma Basic Information, Head Office, Major Market Areas and Its Competitors

Table HUAHAI Basic Information, Head Office, Major Market Areas and Its Competitors



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.